Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Dynamac
    Member
    • Aug 2011
    • 46

    Sequencing Short PCR Products

    We have no experience in Sanger sequencing of small products, 70-100 bp. So far, we've figured out that we'll need BigDye v1.1, a new spectral calibration, maybe a different POP version, and likely a new way to purify the PCR products because Qiagen columns cut off around 100 bp. We'd like to do the cleanup in plate format. In short, we need advice, big time!

    Any suggestions, comments, resources out there? Perhaps it is best to just outsource?

    Thanks.

    Barry
  • rzero
    Junior Member
    • Feb 2011
    • 3

    #2
    Hi, we typically sequence 200-300. Using ExoSAP and EtOH precipitation do work well almost equivalent in quality of the final signal as a column-based method. I recommend using v1.1 (which can be used at 8-fold dilution) and POP6 polymer. You could try the below cond to start with:


    Polymer 3130 POP-6 Polymer
    Capillary Array 16 x 36 cm
    Oven Temperature 60° C
    DC Injection Time 7 sec (increase may be needed for smaller quantity of amplicon)
    DC Run Time 1800 sec

    Comment

    • Dynamac
      Member
      • Aug 2011
      • 46

      #3
      Thanks. We'll probably try the ExoSAP. But I'm afraid we're stuck with POP-7 because the 3730xl doesn't support POP-6.

      Comment

      • MrGuy
        Member
        • Mar 2009
        • 68

        #4
        we use pop7. Just run a slower run module and BD v1.1. There's another dye kit that just came out that will sequence closer to the primer, but requires a bit more thinking about the approach (can't recall exactly). You don't really need to clean the PCR product, just dilute with water (1:10 or 1:100) or do exosap (or exo and sap).

        I use xTerminator for cleanup instead of EtOH (better reproducibility, higher cost for xterminator). Run a low volume (10uL or less) sanger reaction to save on costs.

        Another easy trick is to tail the primer so you can sequence through the primer first (ie, low quality) then go to the sequence fo interest.

        Comment

        • Dynamac
          Member
          • Aug 2011
          • 46

          #5
          Thanks. I'll investigate these ideas. Too bad we can't do this with the 454 platform. I know for a fact that it LOVES small fragments.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          16 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          18 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          24 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          37 views
          0 reactions
          Last Post SEQadmin2  
          Working...